The next major event isn't going to be more clinical trial results. We've just had a clinical trial result and no other clinical trials are underway.
The next major event will be a licensing agreement for AML in a geographic region, including some cash upfront.
This will happen because:
* the AML proofs of concept are now sufficiently complete
* RAC can't perform a loaves and fishes miracle; the cardioprotection and FTO programmes need more cash
* the current SP isn't conducive to a CR.
Add to My Watchlist
What is My Watchlist?
